Audited Supplier
In This Store
KRB Consulting is a professional company operating in the pharmaceutical business engaged in providing services to the global industry peers, especially qualified and experienced in regulatory affairs, GxP compliance, market access and related services. Our goal is to accelerate the regulatory approval for a fast market access with our tailored and cost-friendly solution for each project.
In recent 10 years, KRB has successfully supported for 100+ China APIs and FDFs Pharma in their global market access and GMP inspection activities, continuously promote the internationalization for Chinese pharmaceuticals; Likewise, KRB successfully supported for 50+ overseas Pharma for their products registration and GMP inspection in China mainland. Our goal is to bring sustaining benefits to our customers by the robust services, and promote the compliance for the industry.
金瑞博咨询是一家专业从事药品合规咨询的公司，专注于为全球制药企业提供药品注册事务、GxP合规、市场准入及相关服务，通过为每个项目量身定制落地且具有成本效益的解决方案，以助力项目高效获得监管批准，快速实现国际市场准入。
近10年以来，金瑞博已帮助中国100+制剂和原料药企业实现了在发达国家的市场准入及GMP核查，持续助力中国制药企业的国际化进程；同时也帮助50+境外企业实现了在中国的市场准入及顺利通过中国海外核查。我们的目标是通过不断提高服务质量，使我们的客户得到切实提升和收益，推动整个制药行业的持续合规。
Year of Establishment: 2021
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages: International Approvals/Standards,Contract Manufacturing (CRO,CMO),Reputation,Quality Service
Other Competitive Advantages: In recent 10 years, KRB has successfully supported for 100+ China APIs and FDFs Pharma in their global market access and GMP inspection activities, continuously promote the internationalization for Chinese pharmaceuticals; Likewise, KRB successfully supported for 50+ overseas Pharma for their products registration and GMP inspection in China mainland. Our goal is to bring sustaining benefits to our customers by the robust services, and promote the compliance for the industry. 近10年以来，金瑞博已帮助中国100+制剂和原料药企业实现了在发达国家的市场准入及GMP核查，持续助力中国制药企业的国际化进程；同时也帮助50+境外企业实现了在中国的市场准入及顺利通过中国海外核查。我们的目标是通过不断提高服务质量，使我们的客户得到切实提升和收益，推动整个制药行业的持续合规。
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
